<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30361775</PMID>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>26</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1432-1963</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>25</Day>                    </PubDate>                </JournalIssue>                <Title>Der Pathologe</Title>                <ISOAbbreviation>Pathologe</ISOAbbreviation>            </Journal>            <ArticleTitle>[Three-dimensional reconstruction of solid tumors : Morphological evidence for tumor heterogeneity].</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00292-018-0529-4</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In histopathological routine diagnostics, three-dimensional tissue samples are analyzed histologically and/or immunohistochemically in two-dimensional sectional planes due to the high expenditure of time and the lack of digitization possibilities.</AbstractText>                <AbstractText Label="AIM" NlmCategory="OBJECTIVE">Here, we demonstrate the application of three-dimensional reconstruction to solid tumors and analyze inter-/intratumoral heterogeneity with respect to epithelial-mesenchymal transition (EMT).</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">Tissue samples from pancreatic, lung, colorectal, and breast cancers as well as colorectal liver metastases were serially processed in 4μm sections. For individual analyses, alternating stains (cytokeratin AE1/3, zinc finger E‑box-binding homeobox 1 (ZEB1), eCadherin) were performed. Subsequently, the tumor cells were analyzed for their morphology (epitheloid amoeboid, mesenchymal) and the expression of ZEB1 and eCadherin. For statistical analysis, all tumor cell aggregates were hierarchically annotated and analyzed.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Tumor buds are predominantly associated with the main tumor mass. Furthermore, a shutteling of eCadherin could be observed within tumor cell aggregates smaller than nine cells. ZEB1 is only increasingly expressed in tumor cell groups smaller than five cells.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The initial tumor budding and the subsequent decoupling of the tumor bud from the main tumor mass is most likely a two-part process. However, the EMT is not statistically significantly increased within the tumor bud detached from the main tumor mass. It could be shown that the currently valid and known definition of a tumor bud as a cell cluster of less than or equal to five cells cannot be completely classified in the concept of EMT represented by eCadherin and ZEB1.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Enderle-Ammour</LastName>                    <ForeName>K</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Institut für Klinische Pathologie, Universitätsklinikum Freiburg, Breisacher Straße 115A, 79106, Freiburg, Deutschland.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, Freiburg, Deutschland.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wellner</LastName>                    <ForeName>U</ForeName>                    <Initials>U</Initials>                    <AffiliationInfo>                        <Affiliation>Klinik für Chirurgie, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck, Deutschland.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kocsmar</LastName>                    <ForeName>E</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>II. Institut für Pathologie, Semmelweis Universität, Budapest, Ungarn.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kiss</LastName>                    <ForeName>A</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>II. Institut für Pathologie, Semmelweis Universität, Budapest, Ungarn.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lotz</LastName>                    <ForeName>G</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>II. Institut für Pathologie, Semmelweis Universität, Budapest, Ungarn.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Csanadi</LastName>                    <ForeName>A</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Institut für Klinische Pathologie, Universitätsklinikum Freiburg, Breisacher Straße 115A, 79106, Freiburg, Deutschland.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, Freiburg, Deutschland.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bader</LastName>                    <ForeName>M</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Institut für Klinische Pathologie, Universitätsklinikum Freiburg, Breisacher Straße 115A, 79106, Freiburg, Deutschland.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Schilling</LastName>                    <ForeName>O</ForeName>                    <Initials>O</Initials>                    <AffiliationInfo>                        <Affiliation>Institut für Molekulare Medizin und Zellforschung, Universitätsklinikum Freiburg, Freiburg, Deutschland.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Werner</LastName>                    <ForeName>M</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Institut für Klinische Pathologie, Universitätsklinikum Freiburg, Breisacher Straße 115A, 79106, Freiburg, Deutschland.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Biobank Tumorzentrum Freiburg, Universitätsklinikum Freiburg, Freiburg, Deutschland.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, Freiburg, Deutschland.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bronsert</LastName>                    <ForeName>P</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Institut für Klinische Pathologie, Universitätsklinikum Freiburg, Breisacher Straße 115A, 79106, Freiburg, Deutschland. peter.bronsert@uniklinik-freiburg.de.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Biobank Tumorzentrum Freiburg, Universitätsklinikum Freiburg, Freiburg, Deutschland. peter.bronsert@uniklinik-freiburg.de.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, Freiburg, Deutschland. peter.bronsert@uniklinik-freiburg.de.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>ger</Language>            <PublicationTypeList>                <PublicationType UI="D004740">English Abstract</PublicationType>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>            <VernacularTitle>Dreidimensionale Rekonstruktion solider Tumoren : Morphologische Evidenz für Tumorheterogenität.</VernacularTitle>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>25</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Germany</Country>            <MedlineTA>Pathologe</MedlineTA>            <NlmUniqueID>8006541</NlmUniqueID>            <ISSNLinking>0172-8113</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Cadherins</Keyword>            <Keyword MajorTopicYN="N">Epithelial-mesenchymal transition</Keyword>            <Keyword MajorTopicYN="N">Neoplasms</Keyword>            <Keyword MajorTopicYN="N">Three-dimensional imaging</Keyword>            <Keyword MajorTopicYN="N">Zinc finger E‑box-binding homeobox 1</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30361775</ArticleId>            <ArticleId IdType="doi">10.1007/s00292-018-0529-4</ArticleId>            <ArticleId IdType="pii">10.1007/s00292-018-0529-4</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>